Literature DB >> 11159141

Risk factors for uterine fibroids among women undergoing tubal sterilization.

C R Chen1, G M Buck, N G Courey, K M Perez, J Wactawski-Wende.   

Abstract

Uterine leiomyomas are reported to be the most common benign gynecologic tumors affecting premenopausal women, and they are often associated with considerable morbidity. The purpose of this study was to identify risk factors for uterine fibroids among women undergoing tubal sterilization. Cases comprised women aged 17-44 years whose uterine fibroids were first visualized at the time of tubal sterilization (1978-1979 or 1985-1987) or who reported a history of uterine fibroids (n = 317). Controls were randomly selected from women with no laparoscopic evidence of or history of fibroids (n = 1,268). Adjusted odds ratios were estimated using unconditional logistic regression separately for White (n = 1,235) and African-American (n = 350) women. Risk factors for White women included: age 40-44 years (odds ratio (OR) = 6.3; 95% confidence interval (CI): 3.5, 11.6), > or =5 years since last delivery (OR = 1.9; 95% CI: 1.1, 3.1), lifetime cigarette smoking of > or =1 pack/day (OR = 1.6; 95% CI: 1.1, 2.3), menstrual cycle length of >30 days (OR = 1.6; 95% CI: 1.1, 3.3), and menstrual bleeding for > or =6 days (OR = 1.4; 95% CI: 1.0, 2.0). Parous women were at reduced risk compared with nulliparous women (OR = 0.2; 95% CI: 0.1, 0.3). Advancing age was the only significant risk factor for African-American women (ages 40-44 years, OR = 27.5; 95% CI: 5.6, 83.6). Current oral contraceptive use and elective abortion were not associated with fibroids.

Entities:  

Mesh:

Year:  2001        PMID: 11159141     DOI: 10.1093/aje/153.1.20

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  27 in total

1.  Uterine artery embolisation.

Authors:  Rajeev Bhardwaj
Journal:  Indian Heart J       Date:  2012 May-Jun

Review 2.  Menstruation and the menopausal transition.

Authors:  Siobán D Harlow; Pangaja Paramsothy
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

3.  Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development.

Authors:  Mark Payson; Minnie Malik; Sarah Siti-Nur Morris; James H Segars; Rebecca Chason; William H Catherino
Journal:  Fertil Steril       Date:  2008-08-09       Impact factor: 7.329

4.  Vitamin D and uterine leiomyoma among a sample of US women: Findings from NHANES, 2001-2006.

Authors:  Susanna D Mitro; Ami R Zota
Journal:  Reprod Toxicol       Date:  2015-06-03       Impact factor: 3.143

5.  Uterine leiomyomata in a cohort of Great Lakes sport fish consumers.

Authors:  Anissa Lambertino; Mary Turyk; Henry Anderson; Sally Freels; Victoria Persky
Journal:  Environ Res       Date:  2011-02-09       Impact factor: 6.498

Review 6.  The impact of uterine leiomyomas on reproductive outcomes.

Authors:  H Cook; M Ezzati; J H Segars; K McCarthy
Journal:  Minerva Ginecol       Date:  2010-06

Review 7.  Uterine leiomyoma in a 19-year-old girl: Case report and literature review.

Authors:  A Ernest; A Mwakalebela; B C Mpondo
Journal:  Malawi Med J       Date:  2016-03       Impact factor: 0.875

Review 8.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

Review 9.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

10.  Recruitment and retention of women for clinical leiomyoma trials.

Authors:  Desireé McCarthy-Keith; Sahadat Nurudeen; Alicia Armstrong; Eric Levens; Lynnette K Nieman
Journal:  Contemp Clin Trials       Date:  2009-09-27       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.